Sarah J. Colpitts - Publications

Cell therapy with human interleukin 10-producing ILC2s enhances islet function and inhibits allograft rejection.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: November 20, 2024

Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses.

Journal: Cell reports

Published: February 12, 2024

Single cell profiling of hematopoietic stem cell transplant recipients reveals TGF-β1 and IL-2 confer immunoregulatory functions to NK cells.

Journal: iScience

Published: December 21, 2023

Strategies for optimizing CITE-seq for human islets and other tissues.

Journal: Frontiers in immunology

Published: November 25, 2022

Engineered murine IL-21-secreting leukemia cells induce granzyme B+ T cells and CD4+CD44+CD62L- effector memory cells while suppressing regulatory T cells, leading to long-term survival.

Journal: Cancer immunology, immunotherapy : CII

Published: October 06, 2022

Interactions between islets and regulatory immune cells in health and type 1 diabetes.

Journal: Diabetologia

Published: May 04, 2021

Cellular models for discovering prion disease therapeutics: Progress and challenges.

Journal: Journal of neurochemistry

Published: November 19, 2019

Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model.

Journal: Journal for immunotherapy of cancer

Published: July 04, 2019